Latest On Flexion Therapeutics, Inc (FLXN):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2021-10-24 00:50 EST | News | Flexion Therapeutics: Bullish On The Buyout | N/A |  |
| 2021-10-16 07:43 EST | News | Jasper more than doubles while M&A headlines weekly healthcare performers | N/A | |
| 2021-10-12 05:59 EST | News | Flexion Therapeutics draws downgrade following 'disappointing' Pacira buyout | N/A | |
| 2021-10-11 11:12 EST | News | Pacira Therapeutics acquires Flexion Therapeutics for $8.50 per share in cash plus one CVR | N/A | |
| 2021-08-25 17:17 EST | News | Flexion Therapeutics expands early-stage FX301 post-operative pain management trial | N/A | |
| 2021-08-10 03:57 EST | News | Flexion Therapeutics shares rise on mid-stage ZILRETTA osteoarthritis study results | N/A | |
| 2021-08-06 23:38 EST | News | Flexion Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-05 04:42 EST | News | Flexion Therapeutics EPS beats by $0.06, misses on revenue; reiterates guidance | N/A | |
| 2021-08-05 04:41 EST | News | Flexion Therapeutics, Inc. (FLXN) CEO Michael Clayman on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-22 23:33 EST | News | Flexion Therapeutics: Sector Sell-Off Provides Opportunity To Reload At A Discount | N/A | |
| 2021-07-21 09:01 EST | News | Flexion Therapeutics names William Andrews as chief medical officer | N/A | |
| 2021-07-21 08:39 EST | News | MRIN, ALT, FLXN and FULC among after-hours movers | N/A | |
| 2021-07-21 08:25 EST | News | Flexion Therapeutics adds Utpal Koppikar to its board of directors | N/A | |
| 2021-05-04 19:24 EST | News | It's Time To Buy Flexion Therapeutics As Revenue Is Expected To Grow | N/A | |
| 2021-04-28 14:27 EST | News | Flexion Therapeutics' FX201 shows encouraging action in knee osteoarthritis | N/A | |
| 2021-04-14 07:39 EST | News | Flexion Therapeutics trades high on Q1 prelim revenue, FY21 guidance | N/A | |
| 2021-03-31 21:07 EST | News | Flexion Therapeutics treats first patient in early-stage FX301 trial | N/A | |
| 2021-03-29 10:38 EST | News | The Right Call On Frustrating Flexion Therapeutics | N/A | |
| 2021-03-26 08:57 EST | News | Aspira extends gains as analysts weigh in; Flexion to benefit from Pfizer’s failure in osteoarthritis drug and more in today’s analyst action | N/A | |
| 2021-03-17 00:20 EST | News | Flexion Therapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-03-12 07:41 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-12 03:43 EST | Analyst Rating | The Analyst Target Price has decreased from $20.69 to $20.38. | Neutral | |
| 2021-03-11 07:00 EST | News | Flexion Therapeutics EPS beats by $0.10, misses on revenue | N/A | |
| 2021-03-11 07:00 EST | News | Flexion Therapeutics, Inc. (FLXN) CEO Michael Clayman on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-11 03:38 EST | Earnings Estimate | An EPS average of -$0.50 is estimated for the 2022 year. | Sell | |
| 2021-03-11 03:38 EST | Earnings Estimate | An EPS average of -$0.48 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-01 17:23 EST | News | Flexion shares gain 4% on FDA clearance of FX301 in post-operative pain | N/A | |
| 2021-02-26 15:35 EST | Analyst Rating | The Analyst Target Price has increased from $20.17 to $20.69. | Buy | |
| 2021-01-28 03:53 EST | Analyst Rating | The Analyst Target Price has decreased from $20.25 to $20.17. | Neutral | |
| 2021-01-21 04:01 EST | Analyst Rating | The Analyst Target Price has increased from $18.91 to $20.25. | Buy | |
| 2021-01-17 19:34 EST | News | Flexion Therapeutics: Fighting Through COVID-19 Headwinds | N/A | |
| 2021-01-15 03:38 EST | Analyst Rating | The Analyst Target Price has decreased from $19.18 to $18.91. | Neutral | |
| 2021-01-14 03:39 EST | Analyst Rating | The Analyst Target Price has increased from $18.91 to $19.18. | Buy | |
| 2021-01-13 13:31 EST | News | Flexion Therapeutics anticipates Q4 Zilretta sales of $26.3M | N/A | |
| 2020-12-30 03:44 EST | Analyst Rating | The Analyst Target Price has decreased from $20.25 to $18.91. | Neutral | |
| 2020-11-26 20:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-24 07:56 EST | Analyst Rating | The Analyst Target Price has decreased from $20.5 to $20.25. | Neutral | |
| 2020-11-07 15:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-06 19:43 EST | Analyst Rating | The Analyst Target Price has decreased from $20.58 to $20.5. | Neutral | |
| 2020-11-06 11:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-05 19:43 EST | Earnings Estimate | An EPS average of -$0.52 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-05 04:26 EST | News | Flexion Therapeutics EPS beats by $0.01, beats on revenue | N/A | |
| 2020-10-30 13:07 EST | Analyst Rating | The Analyst Target Price has decreased from $20.75 to $20.58. | Neutral | |
| 2020-10-15 16:50 EST | News | Flexion Therapeutics (FLXN) Presents Q3 Commercial Metrics - Slideshow | N/A | |
| 2020-10-15 00:46 EST | Analyst Rating | The Analyst Target Price has increased from $20.5 to $20.75. | Buy | |
| 2020-10-14 13:13 EST | News | Flexion Therapeutics rallies on ZILRETTA net sales | N/A | |
| 2020-10-14 00:47 EST | Analyst Rating | The Analyst Target Price has decreased from $20.67 to $20.5. | Neutral | |
| 2020-10-06 11:14 EST | News | Flexion's peripheral nerve blocker shows encouraging action preclinical studies | N/A | |
| 2020-09-26 12:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 04:54 EST | Financials | Company financials have been released. | Neutral | |
About Flexion Therapeutics, Inc (FLXN):
Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions in the United States. The company offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) knee pain. It is also involved in the development of FX201, a gene therapy product candidate designed to provide on demand production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, a NaV1.7 inhibitor for the management of post-operative pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts.
General
- Name Flexion Therapeutics, Inc
- Symbol FLXN
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 257
- Fiscal Year EndDecember
- IPO Date2014-02-12
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.flexiontherapeutics.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 6.23
- Price/Book (Most Recent Quarter) 35.62
- Enterprise Value Revenue 7.57
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.74
- Next Year EPS Estimate -$0.60
- Next Quarter EPS Estimate -$0.57
- Profit Margin -133%
- Operating Margin -109%
- Return on Assets -25%
- Return on Equity -6257%
- Revenue 85.55 million
- Earnings Per Share -$4.28
- Revenue Per Share $1.9
- Gross Profit 66.53 million
- Quarterly Earnings Growth 11.2%
View More
Highlights
- Market Capitalization 547.17 million
- EBITDA -150407008
- Analyst Target Price $20.38
- Book Value Per Share $0.34
View More
Share Statistics
- Shares Outstanding 49.92 million
- Shares Float 45.5 million
- % Held by Insiders 434%
- % Held by Institutions 104.39%
- Shares Short 8.16 million
- Shares Short Prior Month 8.19 million
- Short Ratio 14.58
- Short % of Float 22%
- Short % of Shares Outstanding 17%
View More
Technicals
- Beta 1.49
- 52 Week High $14.39
- 52 Week Low $5.35
- 50 Day Moving Average 11.74
- 200 Day Moving Average 11.71
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Flexion Therapeutics, Inc (FLXN) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Flexion Therapeutics, Inc (FLXN) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-10 | $26.31 million | -$0.32 | -$0.45 | 28.7% |
| 2020-09-30 | 2020-11-04 | $N/A | -$0.50 | -$0.51 | 1.96% |
| 2020-06-30 | 2020-08-05 | $N/A | -$0.76 | -$0.67 | -13.86% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.95 | -$0.99 | 4.41% |
| 2019-12-31 | 2020-03-12 | $23.65 million | -$0.87 | -$0.95 | 8.31% |
| 2019-09-30 | 2019-11-07 | $21.79 million | -$1.00 | -$0.95 | -5.11% |
| 2019-06-30 | 2019-08-06 | $16.95 million | -$0.96 | -$1.05 | 8.25% |
| 2019-03-31 | 2019-05-08 | $10.56 million | -$1.09 | -$1.08 | -0.93% |
| 2018-12-31 | 2019-02-28 | $9.54 million | -$1.07 | -$1.17 | 8.74% |
| 2018-09-30 | 2018-11-07 | $6.99 million | -$1.15 | -$1.20 | 3.9% |
| 2018-06-30 | 2018-08-07 | $3.8 million | -$1.16 | -$1.23 | 5.61% |
| 2018-03-31 | 2018-05-08 | $2.19 million | -$1.10 | -$1.33 | 17.5% |
| 2017-12-31 | 2018-03-08 | $355000 | -$1.43 | -$1.13 | -27.11% |
| 2017-09-30 | 2017-11-06 | $N/A | -$1.07 | -$0.99 | -8.49% |
| 2017-06-30 | 2017-08-08 | $N/A | -$0.91 | -$0.83 | -9.45% |
| 2017-03-31 | 2017-05-04 | $N/A | -$0.75 | -$0.73 | -2.94% |
| 2016-12-31 | 2017-03-09 | $N/A | -$0.78 | -$0.72 | -8.89% |
| 2016-09-30 | 2016-11-07 | $N/A | -$0.65 | -$0.63 | -3.17% |
| 2016-06-30 | 2016-08-03 | $N/A | -$0.63 | -$0.68 | 7.35% |
| 2016-03-31 | 2016-05-12 | $N/A | -$0.78 | -$0.61 | -27.51% |
| 2015-12-31 | 2016-03-10 | $N/A | -$0.63 | -$0.58 | -8.3% |
| 2015-09-30 | 2015-11-09 | $N/A | -$0.52 | -$0.60 | 13.33% |
| 2015-06-30 | 2015-08-06 | $N/A | -$0.58 | -$0.54 | -7.41% |
| 2015-03-31 | 2015-05-07 | $N/A | -$0.43 | -$0.56 | 23.21% |
| 2014-12-31 | 2015-03-23 | $N/A | -$0.47 | -$0.53 | 11.32% |
| 2014-09-30 | 2014-11-13 | $N/A | -$0.45 | -$0.55 | 18.18% |
| 2014-06-30 | 2014-08-07 | $N/A | -$0.38 | -$0.52 | 26.92% |
| 2014-03-31 | 2014-05-08 | $N/A | -$0.86 | -$0.52 | -65.38% |
| 2013-12-31 | 2014-03-28 | $N/A | -$4.65 | -$0.51 | -811.76% |
Flexion Therapeutics, Inc (FLXN) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Flexion Therapeutics, Inc (FLXN) Chart:
Flexion Therapeutics, Inc (FLXN) News:
Below you will find a list of latest news for Flexion Therapeutics, Inc (FLXN) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Flexion Therapeutics, Inc (FLXN) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Flexion Therapeutics, Inc (FLXN) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120038731/0001209191-20-038731-index.htm |
| 2020-09-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1419600/000000000020008732/0000000000-20-008732-index.htm |
| 2019-01-22 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000007297119000119/0000072971-19-000119-index.htm |
| 2019-05-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000007297119000265/0000072971-19-000265-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000009375119000297/0000093751-19-000297-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000009375120000574/0000093751-20-000574-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000021545719004033/0000215457-19-004033-index.htm |
| 2020-02-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000081413320000019/0000814133-20-000019-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000083423720005233/0000834237-20-005233-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000108514619000807/0001085146-19-000807-index.htm |
| 2019-04-23 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000108514619001235/0001085146-19-001235-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000108514620000805/0001085146-20-000805-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000110465920021004/0001104659-20-021004-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000114420419007430/0001144204-19-007430-index.htm |
| 2019-02-15 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000114420419008517/0001144204-19-008517-index.htm |
| 2019-12-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000119312519323480/0001193125-19-323480-index.htm |
| 2020-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000119312520147274/0001193125-20-147274-index.htm |
| 2020-05-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1419600/000119312520147375/0001193125-20-147375-index.htm |
| 2020-05-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1419600/000119312520148673/0001193125-20-148673-index.htm |
| 2020-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000119312520148678/0001193125-20-148678-index.htm |
| 2018-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919118040937/0001209191-18-040937-index.htm |
| 2018-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919118046129/0001209191-18-046129-index.htm |
| 2018-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919118046163/0001209191-18-046163-index.htm |
| 2018-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919118054524/0001209191-18-054524-index.htm |
| 2018-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919118054525/0001209191-18-054525-index.htm |
| 2018-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919118054551/0001209191-18-054551-index.htm |
| 2018-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919118058085/0001209191-18-058085-index.htm |
| 2018-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919118058086/0001209191-18-058086-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119002065/0001209191-19-002065-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119002070/0001209191-19-002070-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119002077/0001209191-19-002077-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119002079/0001209191-19-002079-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119002084/0001209191-19-002084-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119002087/0001209191-19-002087-index.htm |
| 2019-01-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119004671/0001209191-19-004671-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016478/0001209191-19-016478-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016492/0001209191-19-016492-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016498/0001209191-19-016498-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016506/0001209191-19-016506-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016512/0001209191-19-016512-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016755/0001209191-19-016755-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016930/0001209191-19-016930-index.htm |
| 2019-03-05 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119017155/0001209191-19-017155-index.htm |
| 2019-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119019135/0001209191-19-019135-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119028497/0001209191-19-028497-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119029182/0001209191-19-029182-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119029970/0001209191-19-029970-index.htm |
| 2019-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119032582/0001209191-19-032582-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119033898/0001209191-19-033898-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038447/0001209191-19-038447-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038454/0001209191-19-038454-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038458/0001209191-19-038458-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038459/0001209191-19-038459-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038460/0001209191-19-038460-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038461/0001209191-19-038461-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038463/0001209191-19-038463-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038758/0001209191-19-038758-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038759/0001209191-19-038759-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038761/0001209191-19-038761-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038762/0001209191-19-038762-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038817/0001209191-19-038817-index.htm |
| 2019-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119045123/0001209191-19-045123-index.htm |
| 2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119045325/0001209191-19-045325-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119045884/0001209191-19-045884-index.htm |
| 2019-08-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119047709/0001209191-19-047709-index.htm |
| 2019-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119052748/0001209191-19-052748-index.htm |
| 2019-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119052753/0001209191-19-052753-index.htm |
| 2019-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119052754/0001209191-19-052754-index.htm |
| 2019-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119052756/0001209191-19-052756-index.htm |
| 2019-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919119052757/0001209191-19-052757-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002271/0001209191-20-002271-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002279/0001209191-20-002279-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002283/0001209191-20-002283-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002285/0001209191-20-002285-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002286/0001209191-20-002286-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002287/0001209191-20-002287-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002305/0001209191-20-002305-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120015098/0001209191-20-015098-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120015110/0001209191-20-015110-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120015120/0001209191-20-015120-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120015128/0001209191-20-015128-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120015140/0001209191-20-015140-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120015148/0001209191-20-015148-index.htm |
| 2020-03-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120018851/0001209191-20-018851-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120023097/0001209191-20-023097-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120028249/0001209191-20-028249-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120032287/0001209191-20-032287-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120032291/0001209191-20-032291-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036247/0001209191-20-036247-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036251/0001209191-20-036251-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036253/0001209191-20-036253-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036257/0001209191-20-036257-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036261/0001209191-20-036261-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036265/0001209191-20-036265-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036278/0001209191-20-036278-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036282/0001209191-20-036282-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120038719/0001209191-20-038719-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120038722/0001209191-20-038722-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120038725/0001209191-20-038725-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120038727/0001209191-20-038727-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120038730/0001209191-20-038730-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120038731/0001209191-20-038731-index.htm |
| 2020-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120042151/0001209191-20-042151-index.htm |
| 2020-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120043107/0001209191-20-043107-index.htm |
| 2020-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120043108/0001209191-20-043108-index.htm |
| 2020-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120043111/0001209191-20-043111-index.htm |
| 2020-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120043112/0001209191-20-043112-index.htm |
| 2020-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120043119/0001209191-20-043119-index.htm |
| 2020-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120043120/0001209191-20-043120-index.htm |
| 2020-08-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120047746/0001209191-20-047746-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1419600/000120919120047749/0001209191-20-047749-index.htm |
| 2019-01-22 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000139077719000008/0001390777-19-000008-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000142284919000053/0001422849-19-000053-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1419600/000142284920000056/0001422849-20-000056-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459018019906/0001564590-18-019906-index.htm |
| 2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1419600/000156459018019913/0001564590-18-019913-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459018027989/0001564590-18-027989-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1419600/000156459018027996/0001564590-18-027996-index.htm |
| 2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459019000144/0001564590-19-000144-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459019000322/0001564590-19-000322-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459019005434/0001564590-19-005434-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1419600/000156459019005465/0001564590-19-005465-index.htm |
| 2019-02-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1419600/000156459019005522/0001564590-19-005522-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1419600/000156459019013344/0001564590-19-013344-index.htm |
| 2019-04-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1419600/000156459019013352/0001564590-19-013352-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459019017172/0001564590-19-017172-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1419600/000156459019017182/0001564590-19-017182-index.htm |
| 2019-06-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459019023011/0001564590-19-023011-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459019029320/0001564590-19-029320-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1419600/000156459019029323/0001564590-19-029323-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459019041708/0001564590-19-041708-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1419600/000156459019041713/0001564590-19-041713-index.htm |
| 2019-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459019045588/0001564590-19-045588-index.htm |
| 2020-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459020000629/0001564590-20-000629-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459020010448/0001564590-20-010448-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1419600/000156459020010490/0001564590-20-010490-index.htm |
| 2020-03-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1419600/000156459020010521/0001564590-20-010521-index.htm |
| 2020-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459020014651/0001564590-20-014651-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1419600/000156459020019691/0001564590-20-019691-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1419600/000156459020019696/0001564590-20-019696-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459020022824/0001564590-20-022824-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1419600/000156459020022827/0001564590-20-022827-index.htm |
| 2020-05-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459020026066/0001564590-20-026066-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459020029026/0001564590-20-029026-index.htm |
| 2020-07-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459020032302/0001564590-20-032302-index.htm |
| 2020-07-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459020032765/0001564590-20-032765-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459020036790/0001564590-20-036790-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1419600/000156459020036837/0001564590-20-036837-index.htm |
| 2020-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459020040679/0001564590-20-040679-index.htm |
| 2020-09-11 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1419600/000156459020043269/0001564590-20-043269-index.htm |
| 2020-09-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1419600/000156459020043722/0001564590-20-043722-index.htm |
| 2020-10-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459020046245/0001564590-20-046245-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1419600/000156459020050450/0001564590-20-050450-index.htm |
| 2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1419600/000156459020050458/0001564590-20-050458-index.htm |
| 2020-11-04 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1419600/000156459020050593/0001564590-20-050593-index.htm |
| 2020-09-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1419600/999999999520002508/9999999995-20-002508-index.htm |
| 2018-10-04 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1419600/999999999718008383/9999999997-18-008383-index.htm |
| 2019-07-12 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1419600/999999999719006126/9999999997-19-006126-index.htm |
Flexion Therapeutics, Inc (FLXN) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Flexion Therapeutics, Inc (FLXN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 434%Institutional Ownership: 10439%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-05-23 | C ANN MERRIFIELD | Director | Buy | 8,000.00 | 12.64 | 101,120.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119032582/0001209191-19-032582-index.htm |
| 2020-01-03 | Neil Bodick | Chief Scientific Officer | Sell | 3,851.00 | 100,153.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002271/0001209191-20-002271-index.htm | ||
| 2019-03-01 | Neil Bodick | Chief Scientific Officer | Buy | 36,000.00 | 100,782.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016492/0001209191-19-016492-index.htm | ||
| 2019-10-06 | Neil Bodick | Chief Scientific Officer | Buy | 4,568.00 | 105,350.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119052748/0001209191-19-052748-index.htm | ||
| 2019-01-03 | Kerry Wentworth | Chief Regulatory Officer | Sell | 622.00 | 12.36 | 7,687.92 | 11,207.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119002084/0001209191-19-002084-index.htm |
| 2020-07-16 | Mark S. Levine | General Counsel | Buy | 38,750.00 | 114,260.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120043108/0001209191-20-043108-index.htm | ||
| 2020-05-07 | David Arkowitz | Chief Financial Officer | Sell | 2,413.00 | 10.88 | 26,253.44 | 117,068.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120028249/0001209191-20-028249-index.htm |
| 2020-06-22 | David Arkowitz | Chief Financial Officer | Buy | 1,303.00 | 10.83 | 14,111.49 | 118,371.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120038730/0001209191-20-038730-index.htm |
| 2020-03-02 | David Arkowitz | Chief Financial Officer | Buy | 31,000.00 | 119,481.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120015120/0001209191-20-015120-index.htm | ||
| 2020-07-16 | SCOTT KELLEY | Chief Medical Officer | Buy | 38,750.00 | 119,710.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120043119/0001209191-20-043119-index.htm | ||
| 2020-07-16 | Kerry Wentworth | Chief Regulatory Officer | Buy | 38,750.00 | 120,180.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120043107/0001209191-20-043107-index.htm | ||
| 2020-07-16 | Christina Willwerth | Chief Strategy Officer | Buy | 38,750.00 | 121,788.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120043112/0001209191-20-043112-index.htm | ||
| 2020-06-10 | C ANN MERRIFIELD | Director | Buy | 4,500.00 | 14,500.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036261/0001209191-20-036261-index.htm | ||
| 2019-01-03 | SCOTT KELLEY | Chief Medical Officer | Sell | 622.00 | 12.36 | 7,687.92 | 15,271.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119002079/0001209191-19-002079-index.htm |
| 2020-07-16 | David Arkowitz | Chief Financial Officer | Buy | 38,750.00 | 157,121.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120043120/0001209191-20-043120-index.htm | ||
| 2020-07-16 | Michael D. Clayman | President and CEO | Buy | 93,750.00 | 160,010.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120043111/0001209191-20-043111-index.htm | ||
| 2020-05-26 | Mark Stejbach | Director | Buy | 2,051.00 | 9.75 | 19,997.25 | 2,051.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120032291/0001209191-20-032291-index.htm |
| 2020-07-09 | ALAN MILINAZZO | Director | Buy | 18,450.00 | 2.20 | 40,499.60 | 22,950.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120042151/0001209191-20-042151-index.htm |
| 2020-06-10 | SAMUEL D COLELLA | Director | Buy | 4,500.00 | 30,004.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036251/0001209191-20-036251-index.htm | ||
| 2019-08-29 | PATRICK J MAHAFFY | Director | Buy | 30,824.00 | 0.16 | 4,931.84 | 30,824.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119047709/0001209191-19-047709-index.htm |
| 2020-05-26 | Michael D. Clayman | President and CEO | Buy | 10,256.00 | 9.75 | 99,996.00 | 346,605.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120032287/0001209191-20-032287-index.htm |
| 2020-06-10 | PATRICK J MAHAFFY | Director | Buy | 4,500.00 | 35,324.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036278/0001209191-20-036278-index.htm | ||
| 2020-01-03 | Mark S. Levine | General Counsel | Sell | 3,724.00 | 43,487.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002285/0001209191-20-002285-index.htm | ||
| 2018-08-09 | David Arkowitz | Chief Financial Officer | Buy | 4,000.00 | 23.42 | 93,680.00 | 44,250.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919118046163/0001209191-18-046163-index.htm |
| 2020-06-10 | ALAN MILINAZZO | Director | Buy | 4,500.00 | 4,500.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036265/0001209191-20-036265-index.htm | ||
| 2020-06-10 | Heath Lukatch | Director | Buy | 4,500.00 | 4,500.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036253/0001209191-20-036253-index.htm | ||
| 2020-06-10 | Sandesh Mahatme | Director | Buy | 4,500.00 | 4,500.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036257/0001209191-20-036257-index.htm | ||
| 2020-06-10 | Scott A Canute | Director | Buy | 4,500.00 | 4,500.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036247/0001209191-20-036247-index.htm | ||
| 2019-03-01 | Mark S. Levine | General Counsel | Buy | 36,000.00 | 45,060.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016506/0001209191-19-016506-index.htm | ||
| 2019-08-08 | SAMUEL D COLELLA | Director | Buy | 2,000.00 | 10.74 | 21,480.00 | 45,333.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119045325/0001209191-19-045325-index.htm |
| 2019-06-21 | Mark S. Levine | General Counsel | Buy | 1,213.00 | 9.81 | 11,899.53 | 46,273.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038762/0001209191-19-038762-index.htm |
| 2018-11-09 | David Arkowitz | Chief Financial Officer | Buy | 4,000.00 | 16.56 | 66,221.60 | 48,250.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919118058085/0001209191-18-058085-index.htm |
| 2020-01-03 | SCOTT KELLEY | Chief Medical Officer | Sell | 3,724.00 | 49,365.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002286/0001209191-20-002286-index.htm | ||
| 2020-01-03 | Kerry Wentworth | Chief Regulatory Officer | Sell | 3,724.00 | 50,061.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002283/0001209191-20-002283-index.htm | ||
| 2019-03-01 | Kerry Wentworth | Chief Regulatory Officer | Buy | 36,000.00 | 50,607.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016930/0001209191-19-016930-index.htm | ||
| 2019-06-21 | Kerry Wentworth | Chief Regulatory Officer | Buy | 389.00 | 9.81 | 3,816.09 | 50,996.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038761/0001209191-19-038761-index.htm |
| 2019-03-01 | SCOTT KELLEY | Chief Medical Officer | Buy | 36,000.00 | 51,271.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016755/0001209191-19-016755-index.htm | ||
| 2020-01-03 | Christina Willwerth | Chief Strategy Officer | Sell | 3,533.00 | 52,473.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002287/0001209191-20-002287-index.htm | ||
| 2019-06-21 | SCOTT KELLEY | Chief Medical Officer | Buy | 2,152.00 | 9.81 | 21,111.12 | 53,423.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038759/0001209191-19-038759-index.htm |
| 2019-10-06 | Kerry Wentworth | Chief Regulatory Officer | Buy | 3,400.00 | 54,396.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119052756/0001209191-19-052756-index.htm | ||
| 2019-03-01 | Christina Willwerth | Chief Strategy Officer | Buy | 36,000.00 | 58,419.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016512/0001209191-19-016512-index.htm | ||
| 2020-04-01 | Melissa Layman | Chief Commercial Officer | Buy | 61,000.00 | 61,000.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120023097/0001209191-20-023097-index.htm | ||
| 2018-07-03 | Neil Bodick | Chief Scientific Officer | Sell | 16,492.00 | 25.00 | 412,300.00 | 62,307.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919118040937/0001209191-18-040937-index.htm |
| 2019-01-03 | Neil Bodick | Chief Scientific Officer | Sell | 746.00 | 12.36 | 9,220.56 | 64,782.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119002070/0001209191-19-002070-index.htm |
| 2020-06-10 | Mark Stejbach | Director | Buy | 4,500.00 | 6,551.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120036282/0001209191-20-036282-index.htm | ||
| 2020-06-22 | Michael D. Clayman | President and CEO | Buy | 1,303.00 | 10.83 | 14,111.49 | 66,260.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120038727/0001209191-20-038727-index.htm |
| 2019-01-03 | Michael D. Clayman | President and CEO | Sell | 3,278.00 | 12.36 | 40,516.08 | 66,810.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119002065/0001209191-19-002065-index.htm |
| 2018-10-08 | Neil Bodick | Chief Scientific Officer | Buy | 4,566.00 | 66,873.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919118054551/0001209191-18-054551-index.htm | ||
| 2019-08-13 | Christina Willwerth | Chief Strategy Officer | Buy | 8,750.00 | 0.16 | 1,400.00 | 67,169.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119045884/0001209191-19-045884-index.htm |
| 2018-11-09 | Michael D. Clayman | President and CEO | Buy | 5,000.00 | 17.10 | 85,476.50 | 69,166.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919118058086/0001209191-18-058086-index.htm |
| 2019-03-12 | Michael D. Clayman | President and CEO | Buy | 4,046.00 | 12.36 | 50,008.56 | 70,856.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119019135/0001209191-19-019135-index.htm |
| 2019-06-21 | Michael D. Clayman | President and CEO | Buy | 1,492.00 | 9.81 | 14,636.52 | 71,424.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038817/0001209191-19-038817-index.htm |
| 2019-08-08 | Michael D. Clayman | President and CEO | Buy | 2,317.00 | 10.85 | 25,136.21 | 72,249.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119045123/0001209191-19-045123-index.htm |
| 2020-03-02 | Mark S. Levine | General Counsel | Buy | 31,000.00 | 74,487.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120015128/0001209191-20-015128-index.htm | ||
| 2019-05-10 | Michael D. Clayman | President and CEO | Buy | 4,012.00 | 12.48 | 50,067.35 | 74,868.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119029182/0001209191-19-029182-index.htm |
| 2018-08-09 | Michael D. Clayman | President and CEO | Buy | 10,000.00 | 22.33 | 223,300.00 | 75,282.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919118046129/0001209191-18-046129-index.htm |
| 2020-06-22 | Mark S. Levine | General Counsel | Buy | 1,023.00 | 10.83 | 11,079.09 | 75,510.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120038722/0001209191-20-038722-index.htm |
| 2018-07-02 | Neil Bodick | Chief Scientific Officer | Sell | 33,508.00 | 25.10 | 841,191.53 | 78,799.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919118040937/0001209191-18-040937-index.htm |
| 2020-03-02 | SCOTT KELLEY | Chief Medical Officer | Buy | 31,000.00 | 80,365.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120015110/0001209191-20-015110-index.htm | ||
| 2020-06-22 | SCOTT KELLEY | Chief Medical Officer | Buy | 595.00 | 10.83 | 6,443.85 | 80,960.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120038725/0001209191-20-038725-index.htm |
| 2020-03-02 | Kerry Wentworth | Chief Regulatory Officer | Buy | 31,000.00 | 81,061.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120015140/0001209191-20-015140-index.htm | ||
| 2020-06-22 | Kerry Wentworth | Chief Regulatory Officer | Buy | 369.00 | 10.83 | 3,996.27 | 81,430.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120038719/0001209191-20-038719-index.htm |
| 2019-05-08 | David Arkowitz | Chief Financial Officer | Sell | 2,248.00 | 10.06 | 22,614.88 | 82,924.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119028497/0001209191-19-028497-index.htm |
| 2020-03-02 | Christina Willwerth | Chief Strategy Officer | Buy | 31,000.00 | 83,473.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120015148/0001209191-20-015148-index.htm | ||
| 2019-03-01 | David Arkowitz | Chief Financial Officer | Buy | 36,000.00 | 85,172.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119016498/0001209191-19-016498-index.htm | ||
| 2019-05-13 | David Arkowitz | Chief Financial Officer | Buy | 4,000.00 | 11.99 | 47,960.00 | 86,924.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119029970/0001209191-19-029970-index.htm |
| 2019-10-06 | Michael D. Clayman | President and CEO | Buy | 14,800.00 | 87,049.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119052754/0001209191-19-052754-index.htm | ||
| 2020-01-03 | David Arkowitz | Chief Financial Officer | Sell | 3,095.00 | 88,481.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919120002279/0001209191-20-002279-index.htm | ||
| 2019-05-31 | David Arkowitz | Chief Financial Officer | Buy | 2,500.00 | 11.05 | 27,626.75 | 89,424.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119033898/0001209191-19-033898-index.htm |
| 2018-10-08 | Michael D. Clayman | President and CEO | Buy | 14,800.00 | 90,082.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919118054525/0001209191-18-054525-index.htm | ||
| 2019-01-03 | Mark S. Levine | General Counsel | Sell | 734.00 | 12.36 | 9,072.24 | 9,060.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119002087/0001209191-19-002087-index.htm |
| 2019-06-21 | David Arkowitz | Chief Financial Officer | Buy | 2,152.00 | 9.81 | 21,111.12 | 91,576.00 | https://www.sec.gov/Archives/edgar/data/1419600/000120919119038758/0001209191-19-038758-index.htm |